MetroDerm Funding: How Much Did They Raise & Key Investors

How Much Did MetroDerm Raise?
Funding & Key Investors

MetroDerm, P.C. has solidified its position within the competitive Georgia healthcare landscape, securing a total capital infusion of $2.3M. This financial trajectory, punctuated by a recent strategic investment of $1.3M, underscores the organization's commitment to scaling its specialized dermatologic services. By leveraging these debt-based financing instruments, the practice continues to enhance its operational footprint across the Atlanta metropolitan area and surrounding counties.

The firm's ability to attract significant backing reflects its robust clinical model and long-standing reputation for excellence in medical and surgical dermatology. As the organization navigates its current lifecycle stage, this capital serves as a critical lever for maintaining high-quality patient care standards while exploring new technological integrations.

What is MetroDerm?

MetroDerm

Hospitals & Physicians Clinics

Physicians Clinics

Medical Practice Management

Founded in 2003 by D.J. Papadopoulos, M.D., MetroDerm, P.C. operates as a comprehensive dermatological practice. With a multidisciplinary team comprising dermatologists, a pathologist, and physician assistants, the company provides a full spectrum of medical and surgical skin care services. Operating across three strategic locations in metro Atlanta and Paulding/West Cobb County, the practice distinguishes itself through a rigorous evaluation process for new medical technologies, ensuring that only safe and efficacious treatments are introduced to its patient base. The company's market position is defined by its focus on ethical standards, continuous professional education, and the cultivation of long-term, trust-based patient relationships.

How much funding has MetroDerm raised?

MetroDerm has raised a total of $2.3M across 2 funding rounds:

2020

Debt

$1M

2021

Debt

$1.3M

Debt (2020): $1M with participation from PPP

Debt (2021): $1.3M led by PPP

Key Investors in MetroDerm

PPP

Public-Private Partnership

What's next for MetroDerm?

Looking ahead, MetroDerm is well-positioned to leverage its recent capital injection to further optimize its clinical infrastructure and service delivery. The strategic focus will likely remain on maintaining the high-touch, patient-centric environment that has become the hallmark of the practice, while simultaneously evaluating opportunities for geographic expansion or the adoption of advanced dermatologic innovations. By balancing fiscal responsibility with clinical advancement, the company aims to reinforce its status as a premier provider in the Georgia healthcare market, ensuring that its operational growth remains aligned with its core mission of providing outstanding medical care to patients of all ages.

See full MetroDerm company page

See More Financial Insights